CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN.
about
Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic AnemiaActivity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell DeathNecroptosis Promotes Staphylococcus aureus Clearance by Inhibiting Excessive Inflammatory Signaling.Caspase-8: not so silently deadly.Mechanisms of regulation and diversification of deubiquitylating enzyme function.Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation.Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis.CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.Caspase-8: regulating life and death.Immunoregulatory effects of necroptosis in bacterial infections.Expression and genetic polymorphism of necroptosis related protein RIPK1 is correlated with severe hepatic ischemia-reperfusion injury and prognosis after hepatectomy in hepatocellular carcinoma patients.Necroptotic signaling is primed in Mycobacterium tuberculosis-infected macrophages, but its pathophysiological consequence in disease is restricted.Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity.ATG16L1 orchestrates interleukin-22 signaling in the intestinal epithelium via cGAS-STINGTNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signalingType I IFNs drive hematopoietic stem and progenitor cell collapse via impaired proliferation and increased RIPK1-dependent cell death during shock-like ehrlichial infection
P2860
Q28071495-B584AE1E-7B7E-4D9D-9E6C-37F8112EB278Q36162984-4C5A64B0-8895-427A-A260-F2EEF2E84D0DQ37211555-70D1B6C8-A228-4859-A74D-373991C24B90Q37625431-1B5AF83E-7B39-473F-BFA4-AD624BEA87D6Q38687124-4BB2E73E-6D3A-43AE-8F14-AF29E7611A0DQ38885379-71144352-ADEC-4D6F-AA04-9D383578BF13Q39105381-3AA75C9B-1172-4B8C-9110-4EB5A64026EEQ39144288-B88A3C02-7D6A-4604-99C4-E7E9D959EC24Q39210955-4566A4E8-AFE6-4504-B442-2267C7D8BAE5Q39277461-86B3EEB4-7780-4AAB-B239-00281660908CQ40515108-6C4CFC7E-4874-42D0-A059-1C5AC5E856E0Q48008378-524C1DAC-0B8B-4628-883A-B4DD649A92AFQ48138531-552E6474-B8EB-4170-B03E-A52DFFB682A8Q48165246-BF2597FD-5794-49A0-9FC8-1B3C041082D0Q58700139-01F0DDA8-D6DC-476F-8B38-4EAF9C74A9C3Q58751569-35E652F1-1CD8-4400-AF8F-DB4E7B9090EDQ58798769-383A5C34-A2AC-49E0-AAC6-BD4DF5A309A7
P2860
CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CYLD Proteolysis Protects Macr ...... PS and Licensed by Type I IFN.
@en
CYLD Proteolysis Protects Macr ...... PS and Licensed by Type I IFN.
@nl
type
label
CYLD Proteolysis Protects Macr ...... PS and Licensed by Type I IFN.
@en
CYLD Proteolysis Protects Macr ...... PS and Licensed by Type I IFN.
@nl
prefLabel
CYLD Proteolysis Protects Macr ...... PS and Licensed by Type I IFN.
@en
CYLD Proteolysis Protects Macr ...... PS and Licensed by Type I IFN.
@nl
P2093
P2860
P921
P1433
P1476
CYLD Proteolysis Protects Macr ...... LPS and Licensed by Type I IFN
@en
P2093
Adrian T Ting
Diana Legarda
Emiko Mizoguchi
Jianke Zhang
Matija Zelic
Michelle A Kelliher
Nimisha Rikhi
Rosalind L Ang
Scott J Justus
Thomas M Moran
P2860
P304
P356
10.1016/J.CELREP.2016.05.032
P577
2016-06-02T00:00:00Z